UPDF AI

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

R. Strassman,C. Qualls,E. Uhlenhuth,R. Kellner

1994 · DOI: 10.1001/ARCHPSYC.1994.03950020022002
Archives of General Psychiatry · 439 Citations

TLDR

Clinical and preliminary quantitative data provide bases for further psychopharmacologic characterization of DMT's properties in humans and may be used to compare the effects of other agents affecting relevant brain receptors in volunteer and psychiatric populations.